Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Intracranial Neoplasm”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableStudy completedNCT02440906
What this trial is testing

Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project

Who this might be right for
Chronic Mental IllnessChronic Physical Illness
University of Florida 1,663
Testing effectiveness (Phase 2)Looking for participantsNCT07132190
What this trial is testing

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Who this might be right for
Brain Metastases, AdultBrain Tumor - MetastaticBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+1 more
Ayal A. Aizer, MD 60
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Ended earlyNCT03539731
What this trial is testing

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Who this might be right for
Healthy SubjectIntracranial NeoplasmGlioblastoma
Guido A. Davidzon, MD, SM 27
Early research (Phase 1)Ended earlyNCT02722512
What this trial is testing

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IIIAnaplastic Ependymoma+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)Study completedNCT00859040
What this trial is testing

Monthly SOM230C for Recurrent or Progressive Meningioma

Who this might be right for
Meningioma
Patrick Y. Wen, MD 34
Early research (Phase 1)Looking for participantsNCT06815029
What this trial is testing

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Ended earlyNCT00021229
What this trial is testing

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 85
Testing effectiveness (Phase 2)Study completedNCT03660761
What this trial is testing

Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors

Who this might be right for
Efficacy and Safety
Rongjie Tao 25
Testing effectiveness (Phase 2)WithdrawnNCT01782976
What this trial is testing

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT02523014
What this trial is testing

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Who this might be right for
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology 124
Testing effectiveness (Phase 2)Study completedNCT00352313
What this trial is testing

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC) 82
Not applicableLooking for participantsNCT04427384
What this trial is testing

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Who this might be right for
Brain Tumor, RecurrentBrain TumorBrain Tumor, Primary+3 more
GT Medical Technologies, Inc. 600
Not applicableEnded earlyNCT04462419
What this trial is testing

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Who this might be right for
Metastatic Intracranial Malignant NeoplasmRecurrent Intracranial Neoplasm
Mayo Clinic 19
Testing effectiveness (Phase 2)Ended earlyNCT00479765
What this trial is testing

/ 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Who this might be right for
Glioblastoma MultiformeBrain Neoplasms
Boston Scientific Corporation 4
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Not applicableUnknownNCT04908267
What this trial is testing

How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas

Who this might be right for
High-grade Glioma
Weiguo Zhang 100
Not applicableStudy completedNCT00777686
What this trial is testing

Measuring Non-Enhancing Glioblastoma Progression

Who this might be right for
Brain TumorGlioblastoma
M.D. Anderson Cancer Center 7
Not applicableActive Not RecruitingNCT01892397
What this trial is testing

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 6
Early research (Phase 1)Looking for participantsNCT03383978
What this trial is testing

Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma

Who this might be right for
Glioblastoma
Johann Wolfgang Goethe University Hospital 42
Next Page